17 Sep, 2026 RNAi Roundtable: Zilebesiran, An Investigational RNAi Therapeutic for Patients with Hypertension and High Cardiovascular Risk

On September 17, 2026, we hosted an online RNAi Roundtable to review progress with zilebesiran, an investigational RNAi therapeutic for patients with hypertension and high cardiovascular risk. 

Access the replay
View the presentation

Pushkal Garg, M.D.
Chief Research & Development Officer

Akshay Desai, M.D., MPH
Harvard Medical School
Mass General Brigham

Ishir Bhan, M.D., MPH
Executive Director, ZENITH Clinical Lead

Simon Fox, Ph.D.
Vice President, Zilebesiran Program Lead